Clinical Trial Update: A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

Jazz Pharmaceuticals has withdrawn its Phase 2 trial of JZP541 in adults with irritability associated with autism spectrum disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Irritability Associated with Autism Spectrum Disorder

Drugs mentioned

• JZP541

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Irritability Associated With Autism Spectrum Disorder, Autism Spectrum Disorder | Phase 2 | Status: WITHDRAWN